Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
PHASE2
This phase II trial tests how well 177Lu-PSMA-617 works in treating patient...
Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
PHASE2
This phase II trial compares the use of 225Ac-PSMA-617 to 177Lu-PSMA-617, a...
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
PHASE2
This clinical trial studies whether measuring circulating tumor deoxyribonu...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium